Abstract:Nucleic acid tests (NATs) are considered as gold standard in molecular diagnosis. To meet the demand for onsite, point-of-care, specific and sensitive, trace and genotype detection of pathogens and pathogenic variants, various types of NATs have been developed since the discovery of PCR. As alternatives to traditional NATs (e.g., PCR), isothermal nucleic acid amplification techniques (INAATs) such as LAMP, RPA, SDA, HDR, NASBA, and HCA were invented gradually. PCR and most of these techniques highly depend on efficient and optimal primer and probe design to deliver accurate and specific results. This chapter starts with a discussion of traditional NATs and INAATs in concert with the description of computational tools available to aid the process of primer/probe design for NATs and INAATs. Besides briefly covering nanoparticles-assisted NATs, a more comprehensive presentation is given on the role CRISPR-based technologies have played in molecular diagnosis. Here we provide examples of a few groundbreaking CRISPR assays that have been developed to counter epidemics and pandemics and outline CRISPR biology, highlighting the role of CRISPR guide RNA and its design in any successful CRISPR-based application. In this respect, we tabularize computational tools that are available to aid the design of guide RNAs in CRISPR-based applications. In the second part of our chapter, we discuss machine learning (ML)- and deep learning (DL)-based computational approaches that facilitate the design of efficient primer and probe for NATs/INAATs and guide RNAs for CRISPR-based applications. Given the role of microRNA (miRNAs) as potential future biomarkers of disease diagnosis, we have also discussed ML/DL-based computational approaches for miRNA-target predictions. Our chapter presents the evolution of nucleic acid-based diagnosis techniques from PCR and INAATs to more advanced CRISPR/Cas-based methodologies in concert with the evolution of deep learning (DL)- and machine learning (ml)-based computational tools in the most relevant application domains.

Diagnostics Based on Nucleic Acid Sequence Variant Profiling: PCR, Hybridization, and NGS Approaches.

Homogeneous Detection Of Dna Sequences Based On Mass Spectrometry In Combination With Nanoparticles Probe

The Development and Application of Nucleic Acid Detection Techniques of Infectious Microorganisms in Pediatrics

Nucleic Acid Tests for Clinical Translation

Next-generation sequencing and its applications in molecular diagnostics

Translating RNA sequencing into clinical diagnostics: opportunities and challenges

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Recent Advance in Digital PCR

Modified Unit-Mediated Strand Displacement Reactions for Direct Detection of Single Nucleotide Variants in Active Double-Stranded DNA

Future microfluidic and nanofluidic modular platforms for nucleic acid liquid biopsy in precision medicine

The Evolution of Nucleic Acid-Based Diagnosis Methods from the (pre-)CRISPR to CRISPR era and the Associated Machine/Deep Learning Approaches in Relevant RNA Design

Advances in Genotyping Detection of Fragmented Nucleic Acids

Artificial Intelligence Enhanced Digital Nucleic Acid Amplification Testing for Precision Medicine and Molecular Diagnostics

Cooperative strand displacement circuit with dual-toehold and bulge-loop structure for single-nucleotide variations discrimination

CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics.

Progress and trends on the analysis of nucleic acid and its modification

Next Generation Sequencing: Latent Applications in Clinical Diagnostics with the advent of Bioinformatic Frameworks

Progress and Trends on the Analysis of Nucleic Acid and Its Modification.

Nucleic Acid-Based Diagnostics for Infectious Diseases in Public Health Affairs

Applications of Digital Polymerase Chain Reaction (dPCR) in Molecular and Clinical Testing

The status quo and future prospects of the next generation sequencing technologies in clinical diagnostics